Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

ClinicalTrials.gov ID: NCT05567952

Public ClinicalTrials.gov record NCT05567952. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 2:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AN INTERVENTIONAL, EFFICACY AND SAFETY, PHASE 2, RANDOMIZED, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE A REPEAT 5-DAY COURSE OF NIRMATRELVIR/RITONAVIR COMPARED TO PLACEBO/RITONAVIR IN PARTICIPANTS AT LEAST 12 YEARS OF AGE WITH REBOUND OF COVID-19 SYMPTOMS AND RAPID ANTIGEN TEST POSITIVITY

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to learn about the safety and effects of nirmatrelvir/ritonavir for the potential treatment of COVID-19 rebound. The study is seeking participants who: * Have completed treatment with nirmatrelvir/ritonavir * Have a rebound in COVID-19 symptoms * Are SARS-CoV-2 (COVID-19) positive All study medications will be taken 2 times a day by mouth for 5 days. The first dose of study medication is taken at the study clinic and the rest at home. We will examine the experiences of people receiving the study medicines to those who do not. This will help us determine if the study medicines are safe and effective. People taking part will be in this study for about 24 weeks. Enrolled participants will need to visit the study clinic at least 8 times during the study.

Study identification

NCT ID
NCT05567952
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
436 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 19, 2022 (Actual)
Primary completion
Sep 27, 2023 (Actual)
Completion
Feb 9, 2024 (Actual)
Last update posted
Oct 8, 2024

2022 – 2024

United States locations

U.S. sites
67
U.S. states
22
U.S. cities
50
Facility City State ZIP Site status
The Institute for Liver Health dba Arizona Clinical Trials Mesa Arizona 85210 —
Abby's Research institute Phoenix Arizona 85031 —
Epic Medical Research - Surprise Surprise Arizona 85378 —
Smart Cures Clinical Research Anaheim California 92806 —
Hope Clinical Research, Inc. Canoga Park California 91303 —
Ascada Health PC dba Ascada Research Fullerton California 92835 —
Ascada Research Fullerton California 92835 —
Paradigm Clinical Research Centers, Inc La Mesa California 91942 —
CVS Health - 8876 - Long Beach Long Beach California 90806 —
Carbon Health - North Hollywood - NoHo West North Hollywood California 91606 —
Paradigm Clinical Research Centers, Inc Wheat Ridge Colorado 80033 —
Emerson Clinical Research Institute - Washington - Connecticut Avenue Washington D.C. District of Columbia 20009 —
Emerson Clinical Research Institute Washington D.C. District of Columbia 20011 —
Palm Harbor Dermatology PA d/b/a TrueBlue Clinical Research Brandon Florida 33511 —
Herco Medical and Research Center Inc Coral Gables Florida 33134 —
NeoClinical Research Hialeah Florida 33016 —
Sweet Hope Research Specialty, Inc Hialeah Florida 33016 —
Unlimited Medical Research Group LLC Hialeah Gardens Florida 33018 —
Asclepes Research Center - Spring Hill Lutz Florida 33549 —
LCC Medical Research Institute Miami Florida 33126 —
Premium Medical Research Corp Miami Florida 33126 —
Global Health Clinical Trials Miami Florida 33135 —
South Florida Research Center Miami Florida 33135 —
Reliant Medical Research Miami Florida 33165 —
Innova Pharma Research Miami Florida 33175 —
Entrust Clinical Research Miami Florida 33176 —
Reed Medical Research Miami Florida 33176 —
Kendall South Medical Center Miami Florida 33185 —
Pro-Care Research Center, Corp. Miami Gardens Florida 33014 —
Omega Research Orlando Orlando Florida 32808 —
NAPA Research Pompano Beach Florida 33064 —
Asclepes Research Center - Spring Hill Spring Hill Florida 34609 —
GCP Research, Global Clinical professionals St. Petersburg Florida 33705 —
Theia Clinical Research - 5th Avenue North St. Petersburg Florida 33710 —
Palm Harbor Dermatology PA d/b/a TrueBlue Clinical Research Tampa Florida 33609 —
Santos Research Center Tampa Florida 33615 —
Clinical Site Partners, LLC dba CSP Orlando Winter Park Florida 32789 —
Clinical Site Partners, LLC dba Flourish Research Winter Park Florida 32789 —
Bingham Memorial Hospital Blackfoot Idaho 83221 —
University of Chicago Medical Center Chicago Illinois 60637 —
Centennial Medical Group Elkridge Maryland 21075 —
University of Massachusetts Chan Medical School Worcester Massachusetts 01655 —
Great Lakes Research Group, Inc. Bay City Michigan 48706 —
C.S. Mott Clinical Research Center (CRC) Detroit Michigan 48201 —
Beaumont Infectious Diseases Research Royal Oak Michigan 48073 —
Olive Branch Family Medical Center Olive Branch Mississippi 38654 —
Mercury Street Medical Group, PLLC Butte Montana 59701 —
Excel Clinical Research, LLC Las Vegas Nevada 89109 —
CVS Health - Site 02815 East Brunswick East Brunswick New Jersey 08816 —
Hackensack Meridian Jersey Shore University Medical Center Neptune City New Jersey 07753 —
Montefiore Medical Center The Bronx New York 10467 —
Onsite Clinical Solutions (secondary location) Charlotte North Carolina 28208 —
OnSite Clinical Solutions Charlotte North Carolina 28208 —
Accellacare - Wilmington Wilmington North Carolina 28401 —
WellNow Urgent Care and Research - Columbus Columbus Ohio 43214 —
Willamette Valley Clinical Studies Eugene Oregon 97404 —
Heritage Valley Multispecialty Group, Inc Beaver Pennsylvania 15009 —
Premier Primary Care Union City Tennessee 38261 —
Nayak Research, LLC Andrews Texas 79714 —
Headlands Research - Brownsville Brownsville Texas 78526 —
Southwest Family Medicine Associates Dallas Texas 75235 —
Next Innovative Clinical Research Houston Texas 77021 —
Next Level Urgent Care Houston Texas 77057 —
Accurate Clinical Research - East Humble Humble Texas 77338 —
Accurate Clinical Research, Inc Humble Texas 77338 —
Sun Research Institute San Antonio Texas 78215 —
Eastside Research Associates Redmond Washington 98052 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05567952, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2024 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05567952 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →